Arch Biopartners Inc. (ACHFF) Financials
ACHFF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 40287 | 2.8 million |
| March 31, 2026 | 333000 | 3.0 million |
| Dec. 31, 2025 | 18243 | 2.6 million |
| Sept. 30, 2025 | 75070 | 2.9 million |
ACHFF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -355003 | ? |
| March 31, 2026 | -64066 | ? |
| Dec. 31, 2025 | -619442 | ? |
| Sept. 30, 2025 | -185217 | ? |
ACHFF Net Income
No data available :(
ACHFF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 2051 | - | - |
| March 31, 2026 | 314022 | - | - |
| Dec. 31, 2025 | 3033 | - | - |
| Sept. 30, 2025 | 1509 | - | - |
ACHFF Shares Outstanding
ACHFF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 2 | 131112 | 166804 | - |
| March 31, 2026 | 2 | 84988 | 169911 | 32469 |
| Dec. 31, 2025 | 3 | 344887 | 678140 | 4839 |
| Sept. 30, 2025 | - | -203605 | 215331 | 955 |
ACHFF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
ACHFF
Price: $0.61
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -29.15
Exchange: OQB
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 38.8 million